Share price was 28c a couple of weeks ago, these are cheap pickings. Good luck getting anywhere near this price after launch. Hold tight folks. IMO GLTAH
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling